Vancouver, British Columbia, December 11, 2018 – Quadron Cannatech Corporation (the “Company” or “Quadron”) – (CSE: QCC), is pleased to announce the appointment of Chand Jagpal as a director of the Company.
Mr. Jagpal has over 20 years’ experience in public company management including accounting/financial disclosure and compliance responsibilities in the medical cannabis, agriculture, biotech, nutraceuticals, real estate development and business software systems industries. He is currently a board member of various public and private companies. Mr. Jagpal recently structured and coordinated a reverse takeover for a California based medical cannabis company and has been a reoccurring authority with quotations on CNN Money, Reuters, and other cannabis specific publications.
Scott Ackerman has resigned as a director of the Company. The Company would like to thank Mr. Ackerman for his past services to the Company.
About Quadron: Quadron provides equipment, products and service solutions for the authorized cannabis industry by providing a full array of end-to-end extraction and processing solutions, including sales of end user delivery options (such as vapor pens) for medical and recreational consumers.
For more information, visit: www.quadroncannatech.com
On behalf of the Board of Directors of
QUADRON CANNATECH CORPORATION
Investor Relations Contact:
KIN Communications Inc.
Caleb Jeffries, VP, Investor Relations
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”. Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.